Viking touts once-a-month weight loss maintenance data
Viking Therapeutics says patients who switched to a once-a-month dosing regimen of its obesity drug did not regain much weight after 12 weeks, bolstering the potential of a less frequent schedule. The company, which is ...
read at Endpoints ↗Neutral
September 22, 2026 11:07 AM EDT R&DPharmaGLP-1 drugs Viking touts once-a-month maintenance data for its weight loss candidate Max Bayer Senior Reporter Viking Therapeutics says patients who switched to a once-a-month dosing regimen of its obesity drug did not regain much weight after 12 weeks, bolstering the … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that